Wegovy, prescribed for obesity, is double the dose of semaglutide compared with Ozempic, prescribed for diabetes, for instance
February 2026: the FDA Commissioner announces targeted enforcement on compounded GLP-1s, naming misleading advertising, unauthorized importation, and pharmacies shipping more than 20 out-of-state prescriptions
Studies have shown the symptoms of intermittent claudication are notably reduced with L-carnitine supplementation
The conversation about long-term use needs to happen before starting the protocol, not after reaching goal weight
The precise mechanisms behind these provocative findings are yet unknown, but I believe that just by improving cardiometabolic health overall, these drugs can decrease risk for blood cancers and several other chronic conditions, he added
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)